Pfizer scores 1 point higher than Johnson & Johnson on SINK's sustainability index.
Pfizer is more sustainable according to SINK's open sustainability index, scoring 39/100 vs Johnson & Johnson's 38/100, a difference of 1 points.
Johnson & Johnson scores 38/100 on the SINK sustainability index (Below expectations). J&J's Scope 1 and 2 emissions fell 38% from 2021, mostly through renewable electricity instruments including unbundled certificates; Scope 1 itself fell only about 3% from 2023 to 2025. It reports Scope 3 by category but states no total, and says most of the recent fall in its largest categories comes from a 2025 methodology change. Only 37% of key suppliers have science-based targets, and its trade-association dues go to groups opposing climate policy.
Pfizer scores 39/100 on the SINK sustainability index (Below expectations). Pfizer discloses robust climate data with GHG Protocol alignment and SBTi validation, but progress is dire: only 15% of its 46% emissions reduction target achieved by 2024, renewable energy stuck at 14% despite RE100 membership, and hazardous waste flat since 2022. Critically, Pfizer's climate messaging is undermined by active membership in trade associations (US Chamber, NAM) that lobby against climate policy.
Both companies are rated on the same 10-question SINK rubric: Scope 1/2/3 carbon footprint, energy source, nature and biodiversity, resource use, water, emissions trajectory, science-based targets, transparency, and controversies. Scores are 0–100, based on public data, and fully reproducible.
See the full leaderboard: 847 companies ranked.
View the full leaderboard →